Ophthalmology News

In this edition, sozinibercept combination therapy shows durability, comparable improvements with aflibercept and more.

A generally healthy 42-year-old female presents for evaluation of anxiety, tremors, weight loss, loose stools and heart racing. Symptoms began shortly after she was let go at work about 4 months ago.

In this edition, FDA approves Vabysmo prefilled syringe for retinal diseases, 4D Molecular Therapeutics updates on retinal disease candidates and more.

Semaglutide was associated with an increased risk for nonarteritic anterior ischemic optic neuropathy — a form of optic neuropathy that can cause blindness — in adults with type 2 diabetes or obesity, recent data show.

In this edition, AI model helps predict anti-VEGF response in DME, Merck to acquire EyeBio and more.

In this edition, FDA accepts new drug application for Eluminex, most mentors in vitreoretinal subspecialty are men and more.

In this edition, PALADIN study navigates IOP-lowering surgery in DME patients, small-molecule eye drop well-tolerated as treatment for retinal vascular diseases and more.

As we discussed in our overview of the private equity, or PE, physician practice model, the buyer in an acquisition is often a PE-sponsored management services organization that purchases the nonclinical aspects of the practice’s business.

In this video, Diana Do, MD, discusses the importance of multidisiplinary care in managing patients with diabetic eye diseases.

Screening patients with psoriasis, uveitis or inflammatory bowel disease for spondyloarthritis could improve early diagnosis, but no existing screening tools are generalizable to all who are at risk, according to a scoping review.